Faster, cheaper, easier, kinder, better. Such are the claims of Capsule, a New York-based pharmacy delivery service (PDS), the customer reviews of which earn glowing praise. Capsule is one of many (and counting) PDS that is disrupting the Rx healthcare market in a big way. With the billion-dollar acquisition by […] keep reading
The cost of confusion: drug pricing in TV ads
Just when we thought we couldn’t further complicate the debate on healthcare policy in America any further, the government is preparing to amplify its voice to a level previously unattained. According to the New York Times, the White House is reviewing the text of a final rule to impose listing drug […] keep reading
America hurts: an opioid nation in pain
This week, the New York Times reported on the sordid background of how the Sackler family, owners of Purdue Pharma and the makers of OxyContin, exerted their ill will on the opportunity to profit off of an opioid crisis they helped bring about. First sell the addiction, and then sell […] keep reading